Part 2|Genetic Variation Implicates Plasma Angiopoietin-2 Hauv Kev Loj Hlob Ntawm Kev Mob Raum Raum Mob Sub-phenotypes

Mar 03, 2022

Nyem qhov no rau ntu 1

Yog xav paub ntxiv thov hu rau emily.li@wecistanche.com


Treatment of Acute Kidney Injury with cistanche to live a better life

Cistanche tuaj yeem txhim kho lub raum ua haujlwm


Kev sib tham

Kev tshawb nrhiav cov noob raug cuam tshuam hauv AKI tau cuam tshuam los ntawm heterogeneity nyob rau hauv kev kho mob phenotype. SivAKIsub-phenotypes, peb tau tshawb pom tias cov noob caj noob ces nyob ze ntawm ANGPT2 noob, rs2920656, tiv thaiv kev txhim kho ntawm AKI-SP2. Kev txheeb xyuas qhov tseeb qhia tau hais tias plasma ANG-2 concentrations mediated 41.5 feem pua ​​​​ntawm kev sib txuas caj ces ntawm rs2920656 thiabAKI-SP2txaus ntshai nyob rau hauv cov ntsiab lus ntawm cov poj koob yawm txwv nyob sab Europe. Tsis tas li ntawd, cov kev sim hauv vitro tau pom tias qhov me me ntawm rs2920656 tuaj yeem ua rau qis dua ANG-2 protein tso tawm los ntawmtib neeg lub raum endothelial hlwb. Tsis tas li ntawd, plasma ANG-2 yog qhov tsawg kawg nkaus tshem tawm, tawm tswv yim tias plasma ANG-2 nce siab yuav tsis zoo li tshwm sim los ntawmraumraug mob. Zuag qhia tag nrho, cov kev tshawb pom no muab.

Treatment of Acute Kidney ANG-2 concentrations by rs2920656 genotype in human microvascular kidney endothelial cells (HKMECs). Of 8 human kidney samples, 2 were CC, 5 were CT and 1 was TT for rs2920656.

Cov pov thawj tias plasma ANG-2 ua lub luag haujlwm ntawm tus tswv tsev cov lus teb rau kev mob hnyav ua rau AKI-SP2. Kev siv zog rau lub hom phiaj Ang-Tie2 axis yuav txwv tsis pub AKI qhov hnyav thiab ua rau cov txiaj ntsig tsis zoo [35]. Cov noob ANPT2 yog 100 feem pua ​​​​zes hauv microcephalin (MCPH1) noob. Kev hloov pauv hauv MCPH1 noob tau cuam tshuam nrog cov kab mob ntawm neurogenesis thiab lub raum cell carcinoma [36]. Peb tau pom tias rs2920656 yog qhov sib txawv intronic hauv MCPH1 uas tswj cov ntshav ANG-2 concentrations. Cov kev tshawb fawb yav dhau los tau txheeb xyuas cov caj ces txawv hauv MCPH1 [37] thiab ANGPT2 [38] uas cuam tshuam nrog ANG-2 concentrations. Nws kuj tseem pom tau tias rs2920656 cuam tshuam MCPH1 kev qhia. Txawm li cas los xij, rau peb txoj kev paub, tsis muaj lub luag haujlwm rau MCPH1 hauv qhov mob hnyav lossis mob ntevmob raumlossis raug mob vascular tau piav qhia. Hauv qhov sib piv, ntau qhov kev tshawb fawb ua ntej thiab kho mob tau pom lub luag haujlwm tseem ceeb ntawm plasma ANG-2 hauv kev txhim kho AKI [16, 39, 40].

Ntau cov ntawv tshaj tawm tau cuam tshuam cov plasma biomarkers ntawm endothelial muaj nuj nqi hauv pathophysiology ntawm AKI [39, 41, 42]. ANG-1 thiab -2 yog vascular endothelial kev loj hlob yam tseem ceeb uas ob leeg khi rau endothelial tyrosine kinase receptor (Tie-2) tab sis muaj cov ntsiab lus nyob ntawm cov dej num [43]. ANG-1 raug tso tawm los ntawm pericytes thiab platelets thiab yog ib qho agonist rau Tie-2 receptor. ANG-1 yog tiv thaiv los ntawm stabilizing lub endothelium thiab tiv thaiv microcirculatory capillary leakage, ib qho cim ntawm AKI [44]. Hauv qhov sib piv, ANG-2 feem ntau ua raws li tus antagonist rau Tie-2 receptor thiab txhawb nqa endothelial permeability [45] thiab o [46, 47]. ANGPT2 noob encodes rau circulating ANG{18}}, uas yog tso tawm los ntawm endothelial hlwb thaum lub sij hawm inflammatory stimulus. Cov kev tshawb fawb tsiaj tau pom tias inhibition ntawm ANG-2 khi, augmenting ANG-1 concentrations [41, 44], lossis ua kom Tie-2 [46] txo qis endothelial leak thiab tiv thaiv AKI. Ua ke cov kev tshawb fawb no cuam tshuam txog lub luag haujlwm ntawm ANG-Tie2 axis hauv AKI. Ntawm no peb qhia txog kev tswj hwm genomic ntawm plasma ANG-2 ua lwm yam uas txhawb nqa lub luag haujlwm ntawm ANG-2 hauv kev txhim kho cov qauv hnyav ntawm AKI, AKI-SP2.

cistanche for improve kidney function

Kev sib raug zoo ntawm plasma ANG-2 thiab kev txhim kho ntawm AKI-SP2 ua rau cov lus nug ntawm seb ANG-2 puas zoo ib yam li creatinine: lim los ntawmraumthiab qib siab tsuas yog qhov cuam tshuam ntawm kev txo lub raum pom. Txhawm rau ua kom pom tias cov ntshav ANG-2 cov ntshav siab tsis yog ib qho cim xwb tab sis ua rau muaj kev loj hlob ntawm AKI hnyav, peb muab ob kab pov thawj. Ua ntej, siv kev tshuaj ntsuam genetic causal inference, peb tau pom tias kev hloov pauv caj ces nyob ze ntawm ANGPT2 noob yog txuam nrog ANG-2 plasma concentrations thiab kev loj hlob ntawm AKI-SP2. Thib ob, tsis zoo li creatinine (113 Da), ANG-2 (57,000 Da) yog ib qho loj molecule uas tsis zoo li yuav tau lim dej tsis tu ncua ntawm glomerulus. Hauv cov neeg mob hnyav, peb tau pom tias lub raum tshem tawm tsawg kawg ntawm ANG-2. Yog li, qhov nce hauv ntshav ANG-2 qhov siab tsis zoo yuav yog vim qhov sib txawv ntawm lub raum pom thiab, hloov pauv, tuaj yeem koom nrog hauv pathophysiology ntawm AKI hauv cov neeg mob hnyav.

Treatment of Acute Kidney ANG-2 Renal Clearance in Subjects with and without AKI

Nws yog ib qho tseem ceeb uas yuav tsum nco ntsoov tias cov kab mob sib txawv ntawm ib tus neeg yuav muaj qhov cuam tshuam me me rau kev txhim kho kab mob vim tias AKI yuav yog tus kab mob polygenic. Lub zog ntawm qhov kev tshuaj ntsuam no yog kev txheeb xyuas cov kab mob sib txawv uas txhawb nqa ANG{{0}} ua qhov laj thawj hauv kev txhim kho AKI. Txawm tias muaj ntau qhov sib txawv nrog qhov loj me me muab lub sijhawm rau kev tshawb nrhiav txog txoj hauv kev tshiab uas muaj peev xwm siv tshuaj ntsuam genetic tshuaj. Piv txwv li, kab mob plawv, zoo ib yam li AKI, yog ib qho polygenic zoo nrog ntau yam kab mob sib txawv ntawm txhua tus piav qhia txog me me ntawm qhov kev pheej hmoo. Txawm li cas los xij, peb SNPs uas tau piav qhia tsuas yog 0.4 mus rau 2 feem pua ​​​​ntawm qhov sib txawv ntawm c-reactive protein ntau tau tso cai rau kev txiav txim siab tias c-reactive protein tsis yog qhov ua rau muaj kab mob ischemic vascular [48], thiab cov kev tshawb pom no tau lees paub hauv cov kev tshawb fawb tom ntej. [49].

Peb txoj haujlwm muaj ob peb lub zog. Ua ntej, peb siv AKI sub-phenotypes los ua kom muaj tseeb hauv cov ntsiab lus phenotype thiab ua kom pom qhov loj me kom pom cov noob caj noob ces. Qhov thib ob, kev soj ntsuam kev tshawb fawb pom tau tias 41.5 feem pua ​​​​ntawm rs2920656-kev pheej hmoo cuam tshuam rau kev tsim AKI-SP2 yog piav qhia los ntawm plasma ANG-2 qib. Qhov no muab cov ntaub ntawv pov thawj kho mob, txhawm rau txhim kho kev ua haujlwm los ntawm kev tshawb fawb tsiaj, qhov kev hloov pauv ntawm plasma ANG-2 cov ntsiab lus tuaj yeem txhim kho cov txiaj ntsig ntawm kev mob hnyav-txuas nrog AKI. Thib peb, txhawm rau suav rau qhov muaj peev xwm ua rau tsis txaus ntseeg thiab txuas Ang-2 ntau lawm tshwj xeeb rauraumcov hlwb endothelial, peb ua tiav cov kev sim hauv vitro siv HKMECs. Plaub, siv cov ICU tshwj xeeb nrog cov qauv sau cov zis thiab ua ntej thiab tom qab kuaj ntshav, peb muaj peev xwm ua kom pom tias tsawg kawg ntawm cov ntshav ANG-2 raug lim los ntawmraum. Yog li, lub koom haum muaj zog ntawm ANG-2 nrograum tshwj xeebCov txiaj ntsig zoo yuav tsis ua rau muaj kev ntxhov siab los ntawm cov teeb meem ntawm kev thim rov qab.

Peb txoj kev kawm muaj kev txwv. Peb tus qauv loj kuj me me. Txawm li cas los xij, peb qhov kev txheeb xyuas qhov zoo (AKI-SP2) tau tso cai rau peb txheeb xyuas cov caj ces nrog rau cov neeg mob hnyav nrog AKI. Thib ob, kev tshuaj ntsuam xyuas tau txwv rau cov neeg mob ntawm cov poj koob yawm txwv nyob sab Europe txhawm rau txo qis cov tshuaj tiv thaiv kab mob, ua kom muaj zog, thiab vim qhov sib txawv ntawm qhov sib txawv ntawm cov haiv neeg keeb kwm. Kev ua haujlwm yav tom ntej tau lees paub los kawm lwm haiv neeg los txiav txim siab seb qhov kev hloov pauv ntawm cov genomic zoo sib xws cuam tshuam rau plasma ANG-2 concentrations. Thib peb, thaum muaj qhov sib txawv hauv qis ANG-2 kev ntsuas hauv PTECs nrog cov me me, cov txiaj ntsig tsis tseem ceeb. Txawm li cas los xij, tib neeg cov qauv yog qhov nyuaj kom tau txais, thiab txawm tias muaj cov qauv me me peb pom cov kev taw qhia zoo ib yam. Thib plaub, vim muaj qhov tshwj xeeb ntawm cov ntaub ntawv no, peb tsis tuaj yeem nrhiav cov neeg mob zoo sib xws los luam peb cov kev tshawb pom. Peb cov ntaub ntawv suav nrog cov neeg mob zoo phenotyped nrog AKI, nrog cov ntaub ntawv genomic, plasma, thiab cov ntaub ntawv kho mob. Txawm li cas los xij, nyob rau hauv plaub tus neeg suav nrog hauv iSPAAR muaj kev coj ua zoo ib yam ntawm rs2920656 thiab kev txhim kho ntawm AKI-SP2. Kev ua haujlwm yav tom ntej tau lees paub kom nkag siab txog qhov cuam tshuam ntawm rs2920656 ntawm kev txhim kho sub-phenotype thiab AKI cov txiaj ntsig tshwj xeeb hauv kev kho mob.

acteoside in cistanche have good effcts to antioxidant

Xaus

Hauv cov ntsiab lus, peb tau txheeb xyuas qhov sib txawv ntawm cov noob caj noob ces nyob ze ntawm ANGPT2 cov noob uas cuam tshuam nrog ntshav ANG-2 ntau thiab kev loj hlob ntawm AKI-SP2 ntawm cov neeg mob hnyav. Peb kuj tau sim lub koom haum no los ntawm kev kawm tiav hauv HKMECs. Peb qhov kev tshawb pom qhia tias plasma ANG-2 ua lub luag haujlwm tseem ceeb hauv kev txhim kho AKI-SP2 thiab ntseeg tias kev siv zog los tsom rau Ang-Tie2 axis tuaj yeem tiv thaiv kev txhim kho ntawm cov txiaj ntsig tsis zoo.

acteoside in cistanche (4)

Cov ntaub ntawv

1. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Lub raum tsis ua haujlwm hauv ICU: kev sib piv ntawm qhov cuam tshuam ntawm lub raum tsis ua haujlwm thiab lub raum theem kawg ntawm ICU cov txiaj ntsig.Lub raumInt. 2002; 62:986–96.

2. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. Mob hnyavraumKev raug mob ua rau muaj kev pheej hmoo ntawm ESRD ntawm cov neeg laus. J Am Soc Nephrol JASN. 2009; 20:223–8.

3. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Kev pheej hmoo ntev ntawm kev tuag thiab lwm yam tshwm sim tsis zoo tom qab mob hnyavraumKev raug mob: kev tshuaj xyuas thiab kev tshuaj xyuas meta. Am J Kidney Dis Off J NatlLub raumPom tau. 2009; 53:961–73.

4. Chawla LS, Eggers PW, Star RA, Kimmel PL. Mob hnyavraumraug mob thiab mob ntevraumkab mob raws li interconnected syndromes. N Engl J Med. 2014; 371:58–66.

5. Stafford-Smith M, Li YJ, Mathew JP, Li YW, Ji Y, Phillips-Bute BG, et al. Genome-wide koom haum txoj kev kawm ntawm mob raum raug mob tom qab coronary bypass graft phais txheeb xyuas qhov raug mob loci. Raum Int. 2015; 88:823–32.

6. Zhao B, Lu Q, Cheng Y, Belcher JM, Siew ED, Nplooj DE, et al. Ib txoj kev tshawb fawb genome-wide los txheeb xyuas ib leeg-nucleotide polymorphisms rau mob raum raug mob. Am J Respir Crit Care Med. 2016; 195:482–90.

7. Barasch J, Zager R, Bonventre JV. Mob raum raug mob: ib qho teeb meem ntawm kev txhais. Lancet Lond Engl. 2017; 389: 779–81.

8. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias vim misclassification nyob rau hauv kev kwv yees ntawm cov txheeb ze txaus ntshai. Am J Epidemiol. 1977; 105: 488–95.

9. Sioux V, González JR, Bouzigon E, Curjuric I, Boudier A, Imboden M, et al. Genetic heterogeneity ntawm asthma phenotypes txheeb xyuas los ntawm kev sib koom ua ke. Eur Respir J. 2014; 43:439–52.

10. Bhatraju PK, Zelnick LR, Herting J, Katz R, Mikacenic C, Kosamo S, et al. Kev txheeb xyuas ntawm mob raum raug mob sub-phenotypes nrog sib txawv molecular kos npe thiab teb rau vasopressin kho. Am J Respir Crit Care Med. 2018; 199:863-72.

11. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, thiab al. Vasopressin tiv thaiv norepinephrine infusion hauv cov neeg mob septic shock. N Engl J Med. 2008; 358:877–87.

12. Wu X, Guo R, Chen P, Wang Q, Cunningham PN. TNF induces caspase-dependent o nyob rau hauv lub raum endothelial hlwb los ntawm ib tug rho- thiab myosin lub teeb saw kinase-dependent mechanism. Am J Physiol Raum Physiol. 2009; 297:F316–26.

13. Xu C, Chang A, Hack BK, Eadon MT, Alper SL, Cunningham PN. TNF- mediated kev puas tsuaj rau glomerular endothelium yog ib qho tseem ceeb ntawm kev raug mob raum mob hauv sepsis. Raum Int. 2014; 85:72–81.

14. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ. Mob raum tsis ua haujlwm hauv Endotoxemia yog tshwm sim los ntawm TNF ua ncaj qha rau TNF Receptor-1 hauv lub raum. J Immunol. 2002; 168:5817–23.

15. Lee ES, Kim ES, Lee HS, Park WS, et al. Amelioration ntawm sepsis los ntawm TIE2 activation-induced vascular tiv thaiv. Sci Transl Med. Xyoo 2016; 8:335ra55.

16. PIB SM. Angiopoietin-Tie2 signaling Axis hauv cov kab mob o. J Am Soc Nephrol JASN. Xyoo 2017; 28: 1973-82.

17. Wei Y, Tejera P, Wang Z, Zhang R, Chen F, Su L, et al. Ib qho kev hloov pauv caj ces tsis zoo hauv LRRC16A / CARMIL1 txhim kho qhov mob ua pa nyuaj ua rau muaj sia nyob los ntawm kev txo qis platelet suav. Am J Respir Crit Care Med. 2017; 195:1353–61.

18. Trinder M, Genga KR, Kong HJ, Blauw LL, Lo C, Li X, et al. Cholesteryl Ester hloov cov protein cuam tshuam cov lipoprotein ntau ntom ntom thiab muaj sia nyob hauv Sepsis. Am J Respir Crit Care Med. 2019; 199:854–62.

19. Reilly JP, Wang F, Jones TK, Palaksappa JA, Anderson BJ, Shashaty MGS,

ua al. Plasma angiopoietin-2 raws li qhov muaj peev xwm ua rau muaj txiaj ntsig hauv kev txhim kho sepsis-associated ARDS: pov thawj los ntawm Mendelian randomization thiab kev tshuaj xyuas kev sib kho. Intensive Care Med. 2018; 44: 1849–58.

20. Bhatraju PK, Mukherjee P, Robinson-Cohen C, O'Keefe GE, Frank AJ,

Christie JD, et al. Mob raum raug mob subphenotypes raws li

creatinine trajectory txheeb xyuas cov neeg mob muaj kev pheej hmoo ntawm kev tuag. Crit Care Lod Engl. Xyoo 2016; 20:372.

21. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, et al. Randomized, tshuaj placebo-tswj tshuaj ntsuam xyuas ntawm aerosolized2- agonist rau kev kho mob ntawm lub ntsws raug mob. Am J Respir Crit Care Med. 2011; 184:561–8.

22. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (Ards) Clinical Trials Network, Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, Wiedemann HP, et al. pulmonary-artery piv rau central venous catheter los qhia kev kho mob ntsws mob. N Engl J Med 2006; 354: 2213–2224.

23. Rice TW, Wheeler AP, Thompson BT, de Boisblanc BP, Steingrub J, Rock P, et al. Enteral omega -3 fatty acid, gamma-linolenic acid, thiab antioxidant supplementation nyob rau hauv mob ntsws mob. JAMA. 2011; 306:1574–81.

24. Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, Christiani DC. Polymorphisms hauv mannose-binding lectin -2 noob thiab mob ua pa nyuaj siab. Crit Care Med. 2007; 35:48–56.

25. Liu KD, Glidden DV, Eisner MD, Parsons PE, Ware LB, Wheeler A, et al. Predictive thiab pathogenetic tus nqi ntawm plasma biomarkers rau mob raum raug mob rau cov neeg mob uas mob ntsws mob. Crit Care Med. 2007; 35:2755–61.

26. Liu KL, Li KT, Chang CH, Chen YC, Lin SM, Chu PH. Nce ntshav thrombomodulin thiab angiopoietin -2 kwv yees kev loj hlob ntawm mob raum raug mob rau cov neeg mob uas mob myocardial infarction. Crit Care Lod Engl. Xyoo 2014; 18: R100.

27. Siew ED, Matheny ME, Ikizler TA, Lewis JB, Miller RA, Waitman LR, et al. Feem ntau siv surrogates rau cov hauv paus hauv lub raum kev ua haujlwm cuam tshuam rau kev faib tawm thiab kev kwv yees ntawm mob raum raug mob. Raum Int. 2010; 77:536–42.

28. Howie BN, Donnelly P, Marchini J. Ib txoj hauv kev hloov pauv tau thiab raug genotype imputation rau tiam tom ntej ntawm genome-wide Association kev tshawb fawb. PLoS Genet. 2009;5:e1000529.

29. Marchini J, Howie B. Genotype imputation rau genome-wide koom nrog kev tshawb fawb. Nat Rev Genet. 2010; 11:499–511.

30. Lee PH, Bergen SE, Perlis RH, Sullivan PF, Sklar P, Smoller JW, et al. Modifiers thiab subtype-specific tsom xam nyob rau hauv tag nrho-genome kev tshawb fawb koom haum: ib tug zoo li lub hauv paus. Hum Hered. 2011; 72:10–20.

31. Bhatraju P, Hsu C, Mukherjee P, Glavan BJ, Burt A, Mikacenic C, et al. Kev koom tes ntawm ib leeg nucleotide polymorphisms hauv FAS txoj hauv kev thiab mob raum raug mob. Crit Care Lod Engl. Xyoo 2015; 19:368.

32. Yeboah J, Delaney JA, Nance R, McClelland RL, Polak JF, Sibley CT, et al. Kev kho kom haum xeeb ntawm cov kab mob plawv muaj feem cuam tshuam los ntawm cov kab mob subclinical vascular: kev kawm ntau haiv neeg ntawm atherosclerosis. Arterioscler Thromb Vasc Biol. 2014; 34:1778–83.

33. Kosuke Imai, Lukas Keele, Teppei Yamamoto. Kev txheeb xyuas, kev xav, thiab kev ntsuam xyuas qhov kev xav rau qhov ua rau muaj kev sib haum xeeb. JSTOR. 2010; 25:51–71.

34. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Kev soj ntsuam kev sib koom ua ke muaj txiaj ntsig zoo dua li kev txheeb xyuas rov ua dua rau ob-theem genome-wide kev tshawb fawb koom haum. Nat Genet. 2006; 38:209–13.

35. Higgins SJ, Purcell LA, Silver KL, Tran V, Crowley V, Hawkes M, et al. Dysregulation ntawm angiopoietin-1 plays lub luag hauj lwm mechanistic nyob rau hauv lub pathogenesis ntawm cerebral malaria. Sci Transl Med. Xyoo 2016; 8:358ra128.

36. Pulvers JN, Journiac N, Arai Y, Nardelli J. MCPH1: lub qhov rais rau hauv lub hlwb kev loj hlob thiab evolution. Pem hauv ntej Cell Neurosci. 2015 [cited 2019 Mar 19]; 9.

37. Lieb W, Chen MH, Larson MG, Safa R, Teumer A, Baumeister SE, et al. Genome-wide koom nrog kev tshawb fawb txog kev loj hlob ntawm endothelial. Circ Cardiovasc Genet. 2015; 8:389–97.

38. Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, Bellamy S, et al. ANGPT2 genetic variant yog txuam nrog kev raug mob ntawm lub ntsws raug mob thiab hloov ntshav plasma angiopoietin -2 isoform ratio. Am J Respir Crit Care Med. 2011; 183:1344–53.

39. Jongman RM, van Klarenbosch J, Molema G, Zijlstra JG, de Vries AJ, van Meurs M. Angiopoietin/Tie2 Dysbalance yog txuam nrog mob raum raug mob tom qab phais plawv pab los ntawm cardiopulmonary bypass. PLoS Ib. 2015; 10:e0136205.

40. Robinson-Cohen C, Katz R, Nqe BL, Harju-Baker S, Mikacenic C, Himmelfarb J, et al. Lub koom haum ntawm cov cim ntawm endothelial dysregulation Ang1 thiab Ang2 nrog mob raum raug mob hauv cov neeg mob hnyav. Crit Care Lod Engl. Xyoo 2016; 20:207.

41. David S, Park JK, van Meurs M, Zijlstra JG, Koenecke C, Schrimpf C, et al. Kev tswj xyuas mob hnyav ntawm cov tshuaj Angiopoietin recombinant -1 ameliorates ntau yam kab mob hauv lub cev tsis ua haujlwm thiab txhim kho txoj sia nyob hauv murine sepsis. Cytokine. 2011; 55:251–9.

42. Kümpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, et al. Angiopoietin-2 hauv cov neeg mob xav tau kev kho lub raum hloov hauv ICU: cuam tshuam rau lub raum raug mob, ntau yam kab mob hauv nruab nrog cev, thiab qhov tshwm sim. Intensive Care Med. 2010; 36:462–70.

43. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 yog ib feem agonist / antagonist ntawm Tie2 signaling hauv endothelium. Mol Cell Bio. 2009; 29:2011–22.

44. Lee HS, Kim SH, Lee WS, Lee WS, Lee HS, et al. COMP-angiopoietin - 1 txo lipopolysaccharide-induced mob raum raug mob. Raum Int. 2009; 76:1180–91.

45. Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, et al. Angiopoietin- 2 sib txawv tswj cov angiogenesis los ntawm TIE2 thiab integrin signaling. J Clin Invest. 2012; 122: 1991–2005.

46. ​​Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, et al. Angiopoietin-2 sensitizes endothelial hlwb rau TNF-alpha thiab muaj lub luag haujlwm tseem ceeb hauv kev ua kom mob. Nat Med. 2006; 12:235–9.

47. Higgins SJ, De Ceunynck K, Kellum JA, Chen X, Gu X, Chaudhry SA, et al. Tie2 tiv thaiv vasculature tiv thaiv thrombus tsim nyob rau hauv lub cev o. J Clin Invest. 2018; 128: 1471–84.

48. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetic elevated C-reactive protein thiab ischemic vascular kab mob. N Engl J Med. 2008; 359:1897–908.

Kev sib koom ua ke ntawm cov xwm txheej txaus ntshai; Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration thiab kev pheej hmoo ntawm kab mob plawv, mob hlab ntsha tawg, thiab kev tuag: tus neeg koom nrog meta-kev tshuaj ntsuam. Lancet. 2010; 375 (9709): 132-40


Koj Tseem Yuav Zoo Li